Research Synthesis: Fasting Intervention Intermittent Fasting If Effects

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Resolve the duplicate sentences in the Discussion section and produce a clean final render of the long-form manuscript.
2. Reconcile the outcome-class direction coding between the Findings Map, the Results table, and the Cross-Domain Synthesis so that every source in every slice has a single, traceable direction code that the rest of the paper cites consistently.
3. Either (a) explicitly enumerate which source counts as the '1 mechanistic or model-system source' in the Findings Map or (b) remove the mechanistic-count claim from the Abstract and Methods.
4. Tighten the Conclusion to match the bounded claim posture used in the Abstract and Cross-Domain Synthesis — do not allow soft lifestyle recommendations to slip into a paper that explicitly disclaims broad clinical or policy claims.
5. Reconcile the source-admission funnel counts and explain how the 73 classified candidates resolve to 66 admitted final sources, including how 'partial-only' and 'mixed partial-or-none' candidates are handled.
6. Add the surrogate-endpoint citation (Ioannidis 2005) to the References section or remove the inline citation.

Major issues

• Repeated duplicate sentences in the Discussion (e.g., 'Population specificity constrains external validity in three directions.' and 'The endpoint scope of the corpus is narrow.' appear twice), suggesting rendering artifacts that materially degrade a long synthesis.
• The Results table for the primary cardiometabolic slice reports the 'strongest signal' as 'unclear' across all outcome classes while the Results Summary then re-describes the same sources as 'mixed' — the table column and summary are internally inconsistent and the synthesis is forced to interpret a slice that has not been cleanly directionally coded.
• Cross-Domain Synthesis uses 'mixed/null/unclear' counts that disagree with the Findings Map (e.g., the Findings Map shows a handful of direct positive sources, but the cross-domain paragraph describes the cardiometabolic slice as 'mixed=4, negative=4, null=6, positive=4, unclear=23' without a clear audit trail for each of the 41 sources in that slice).
• The paper claims the corpus contains '11 direct clinical sources' and '1 mechanistic or model-system source,' but the Findings Map does not code a dedicated 'mechanistic/model-system' row — the 1-mechanistic claim is unsupported by the visible evidence table.
• The Conclusion states IF 'may support… as a general health or lifestyle intervention where otherwise indicated' — a soft clinical recommendation that outruns the bounded evidence claim made in the Abstract and the rest of the paper.

Minor issues

• Several bundle citations (e.g., Heart 2024 [bundle:6] P=0.01; Barve 2025 [bundle:19] '8% reduction in body weight') are accurate to the source excerpts but are stated without confidence intervals or sample sizes in the Results narrative.
• 'Source-context map' in Results introduces population/regimen slices (aging, skeletal, transplant, dosing, oncology) that are not cross-referenced anywhere else in the paper and add no analytical weight.
• The Methods section lists 'Admitted final sources: 66' in the funnel but the eligibility counts (73 classified, 20 with no extractable claims, 4 none-only, 51 mixed partial-or-none, 16 partial-only, 29 strict high-confidence, 66 admitted) do not reconcile arithmetically; the funnel needs clarification.
• 'Resource: surrogate endpoint, Ioannidis 2005' is cited inline in Discussion with no corresponding entry in the reference list or source bundle.
• The paper title contains 'full paper' which is a rendering artifact and should be removed before publication.

Reviewer note

The submission is a 66-source research synthesis on intermittent fasting that, at the section level, shows the right shape: an explicit Methods block with a PRISMA-ScR framing, a Quantitative Evidence Index-style table per outcome class, a Cross-Domain Synthesis with explicit convergence/divergence discussion, a Boundary-Condition Matrix, and a layered limitations section. The source bundle is large, recent, and supports the claim that the direct evidence is thin (11 direct clinical sources) and that the cardiometabolic slice dominates. The cross-domain paragraph is honest that mechanistic plausibility coexists with mixed or sparse human RCT data, which is the correct verdict for this topic in 2026. However, several material defects prevent acceptance in current form. The Discussion contains repeated duplicate paragraphs ('Population specificity constrains external validity in three directions.' and 'The endpoint scope of the corpus is narrow.' appear twice each), which are rendering artifacts in a manuscript of this length. More substantively, the Results table's 'strongest signal' column is 'unclear' for every outcome class while the Results Summary simultaneously labels most slices 'mixed' — the table and summary cannot both be true without an explicit coding rule, and the paper does not provide one. The Cross-Domain Synthesis also relies on untraceable per-slice counts (e.g., 'mixed=4, negative=4, null=6, positive=4, unclear=23' for the 41-source cardiometabolic slice) that are not auditable against the Findings Map as shown. The Conclusion drifts into a soft clinical recommendation ('may support… as a general health or lifestyle intervention where otherwise indicated') that outruns the bounded claim posture used everywhere else. The Methods funnel arithmetic does not reconcile. And the Abstract's claim of '1 mechanistic or model-system source' is not represented in the Findings Map. Source grounding is solid where the bundle is explicit: Herz 2024 (P=0.01 ADF BMI), Tay 2020 (HbA1c p<0.001), Barve 2025 (8% weight loss, 16% fat reduction, p=0.001 for lipids), Obermayer 2022 (P=0.012, P<0.001), Karahan 2025 (p<0.05) all check out against the source excerpts, and the disagreements (Khalafi 2024a vs Kang 2022; Koh 2025 vs Li 2026; Huo 2025 vs Li 2026; Lu 2025 vs Couto-Alfonso 2026 on HbA1c) are real and source-traceable. That keeps source_grounding at 4. Net call: the manuscript has the bones of an elite-tier synthesis — explicit methods, outcome-class separation, traceable numerics, a defensible claim posture — but the duplicate text, internal direction-coding inconsistencies, and the unsupported mechanistic-source count plus the soft overclaim in the Conclusion mean it needs bounded revision before it can be accepted. This is closer to revise than to reject because none of the defects requires a scope reset, and the underlying evidence handling is sound once the coding is reconciled and the duplicate paragraphs are removed.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v12-grounded-integrity